Overview

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

Status:
Completed
Trial end date:
2021-07-21
Target enrollment:
0
Participant gender:
Female
Summary
This phase II study is assessing the correlation between M1/M2 macrophage polarization determined by tumor immunohistochemistry analysis and [18F]DPA-714 PET/CT binding (qualitative and texture analysis) in patients with operable triple negative breast cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Institut Cancerologie de l'Ouest
Collaborators:
SIRIC ILIAD
SIRIC ILIAD : regional consortium led by the health cooperation consortium
Criteria
Inclusion Criteria:

- 18 Years and older

- Triple negative primary breast cancer based on immunohistochemical results as follows:

- Estrogen receptor < 10%

- And Progesterone receptors < 10%

- And HER2 (Human Epidermal Growth Factor Receptor-2) not amplified or not
overexpressed

- Patient with a primary tumor eligible for primary surgery

- Performance Status equal to 0 or 1

- Fertile patients must use effective contraception

- Patient must be affiliated to a Social Health Insurance

- Written informed consent

Exclusion Criteria:

- Patient with No triple negative breast cancer

- Patient with inflammatory breast cancer

- Patient with metastatic breast cancer

- Patient receiving cancer treatments such as chemotherapy, immunotherapy, biologic
response modifiers, hormonal therapy, and radiotherapy BEFORE the biopsy and PET scans
are performed

- Treated diabetes with fasting blood glucose > 10 mmol/L

- Patient who received antibiotics and/or steroidal and/or non-steroidal
anti-inflammatory drugs within 30 days PRIOR to [18F]-DPA-714 PET scan

- Contraindication to MRI (implants or metallic prosthesis, severe claustrophobia,
pacemaker ...)

- Patient deprived of liberty, under a measure of safeguard of justice, under
guardianship or under the authority of a guardian

- Pregnant or nursing patient

- Agitation; impossibility of lying motionless for at least 1 hour, or known
claustrophobia